AXL and non-small cell lung carcinoma: Therefore, it implies that there is a correlation between high AXL expression and gefitinib-resistance in NSCLC cells, whereas no correlation was found between AXL expression and gefitinib sensitivity in the gefitinib-sensitive cells.